Chandra Mani Adhikari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chandra Mani Adhikari has a total of 169 co-authors. Here are the top co-authors by number of shared publications:
Amrit Bogati
Department of Cardiology, Shahid Gangalal National Heart Centre, Kathmandu, Nepal
21 shared publicationsDipanker Prajapati
Department of Cardiology, Shahid Gangalal National Heart Centre, Kathmandu, Nepal
21 shared publicationsRabi Malla
Department of Cardiology, Shahid Gangalal National Heart Centre, Bansbari, Kathmandu, Nepal
15 shared publicationsManish Shrestha
Department of Pediatrics, Shahid Gangalal National Heart Centre, Kathmandu, Nepal
10 shared publicationsSujeeb Rajbhandari
Department of Cardiology, Shahid Gangalal National Heart Centre, Kathmandu, Nepal
9 shared publicationsArun Maskey
Senior Consultant Cardiologist, Department of Cardiology, Shahid Gangalal National Heart Center, Nepal
6 shared publications
Latest Publications
- Open Access
- 8 July 2026
- Published by Nepal Journals Online (JOL) in Journal of Nobel Medical College
- Vol. 15 (1) , 110-112
Balloon Pulmonary Valvuloplasty with Mammoth Balloon
Balloon pulmonary valvuloplasty is standard therapy for pulmonary stenosis. The procedure can be done with different balloon catheter. We report a Balloon pulmonary valvuloplasty with the Mammoth balloon in an adult with severe pulmonary stenosis. The device showed good trackability, stability, and rapid inflation. Mammoth balloon appears effective, though larger studies are needed to confirm long-term outcomes
- 8 July 2026
- Published by Nepal Journals Online (JOL) in Journal of Nobel Medical College
- Vol. 15 (1) , 110-112
Open AccessBalloon Pulmonary Valvuloplasty with Mammoth Balloon
Balloon pulmonary valvuloplasty is standard therapy for pulmonary stenosis. The procedure can be done with different balloon catheter. We report a Balloon pulmonary valvuloplasty with the Mammoth balloon in an adult with severe pulmonary stenosis. The device showed good trackability, stability, and rapid inflation. Mammoth balloon appears effective, though larger studies are needed to confirm long-term outcomes
- Open Access
- 28 June 2026
- Published by Nepal Journals Online (JOL) in Journal of National Heart and Lung Society Nepal
- Vol. 5 (1) , 61-71
Device Closure of Patent Ductus Arteriosus in Adults
Patent ductus arteriosus (PDA) persisting into adulthood is an uncommon but clinically significant congenital heart condition, representing the third most common congenital cardiac lesion in adults. Clinical presentation varies widely, from asymptomatic cases with incidental murmurs to complications such as left ventricular (LV) volume overload, pulmonary arterial hypertension(PAH), endarteritis, and Eisenmenger physiology. Classification is based on duct size and hemodynamic impact, guiding management decisions. Untreated PDA in adults carries risks including arrhythmias, LV dysfunction, progressive PAH, and endarteritis, which remains a leading cause of mortality. Current guidelines recommend closure when technically feasible, particularly in the presence of LV overload or favorable pulmonary vascular resistance.While surgical closure was historically the gold standard, transcatheter device closure is now the first-line treatment due to lower morbidity, shorter recovery, and high success rates. However, adult PDA closure presents unique challenges, including calcification, tortuosity, and complex anatomy, necessitating precise imaging and appropriate device sizing. Complications such as device embolization, residual shunt, and LV dysfunction may occur but are infrequent.
- 28 June 2026
- Published by Nepal Journals Online (JOL) in Journal of National Heart and Lung Society Nepal
- Vol. 5 (1) , 61-71
Open AccessDevice Closure of Patent Ductus Arteriosus in Adults
Patent ductus arteriosus (PDA) persisting into adulthood is an uncommon but clinically significant congenital heart condition, representing the third most common congenital cardiac lesion in adults. Clinical presentation varies widely, from asymptomatic cases with incidental murmurs to complications such as left ventricular (LV) volume overload, pulmonary arterial hypertension(PAH), endarteritis, and Eisenmenger physiology. Classification is based on duct size and hemodynamic impact, guiding management decisions. Untreated PDA in adults carries risks including arrhythmias, LV dysfunction, progressive PAH, and endarteritis, which remains a leading cause of mortality. Current guidelines recommend closure when technically feasible, particularly in the presence of LV overload or favorable pulmonary vascular resistance.While surgical closure was historically the gold standard, transcatheter device closure is now the first-line treatment due to lower morbidity, shorter recovery, and high success rates. However, adult PDA closure presents unique challenges, including calcification, tortuosity, and complex anatomy, necessitating precise imaging and appropriate device sizing. Complications such as device embolization, residual shunt, and LV dysfunction may occur but are infrequent.
- Open Access
- 29 May 2026
- Published by Nepal Journals Online (JOL) in Nepalese Heart Journal
- Vol. 23 (1) , 55-57
Transcatheter Closure of Ruptured Sinus of Valsalva Aneurysm: Early Experience from Nepal
Background: Ruptured sinus of Valsalva aneurysm (RSOV) is a rare but potentially life-threatening condition traditionally managed with surgery. Transcatheter closure (TCC) has recently emerged as a less invasive alternative. Case Summary: We report two adult patients; a 27-year-old male and a 48-year-old female, with RSOV arising from the non-coronary sinus and rupturing into the right atrium. Both presented with palpitations and dyspnea. Multimodality imaging confirmed the diagnosis. TCC was successfully performed using a Cera duct occluder in the first case and a Cocoon duct occluder in the second. Post-procedure imaging showed optimal device position, preserved aortic valve function, and no significant residual shunt, with no procedural complications. Conclusion: Transcatheter closure of RSOV is a safe and effective alternative to surgery in selected patients.
- 29 May 2026
- Published by Nepal Journals Online (JOL) in Nepalese Heart Journal
- Vol. 23 (1) , 55-57
Open AccessTranscatheter Closure of Ruptured Sinus of Valsalva Aneurysm: Early Experience from Nepal
Background: Ruptured sinus of Valsalva aneurysm (RSOV) is a rare but potentially life-threatening condition traditionally managed with surgery. Transcatheter closure (TCC) has recently emerged as a less invasive alternative. Case Summary: We report two adult patients; a 27-year-old male and a 48-year-old female, with RSOV arising from the non-coronary sinus and rupturing into the right atrium. Both presented with palpitations and dyspnea. Multimodality imaging confirmed the diagnosis. TCC was successfully performed using a Cera duct occluder in the first case and a Cocoon duct occluder in the second. Post-procedure imaging showed optimal device position, preserved aortic valve function, and no significant residual shunt, with no procedural complications. Conclusion: Transcatheter closure of RSOV is a safe and effective alternative to surgery in selected patients.
- Open Access
- 28 December 2025
- Published by Nepal Journals Online (JOL) in Journal of Advances in Internal Medicine
- Vol. 14 (2) , 79-83
Transcatheter aortic valve implantation in a patient with type 0 bicuspid aortic valve with severe stenosis and calcium extending in to LVOT
Transcatheter aortic valve implantation is the most preferred treatment for aortic stenosis in elderly patients at high surgical risk. We present a case experience of Transcatheter aortic valve implantation using a balloon-expandable Myval transcatheter heart valve in a Type 0 bicuspid aortic stenosis.
- 28 December 2025
- Published by Nepal Journals Online (JOL) in Journal of Advances in Internal Medicine
- Vol. 14 (2) , 79-83
Open AccessTranscatheter aortic valve implantation in a patient with type 0 bicuspid aortic valve with severe stenosis and calcium extending in to LVOT
Transcatheter aortic valve implantation is the most preferred treatment for aortic stenosis in elderly patients at high surgical risk. We present a case experience of Transcatheter aortic valve implantation using a balloon-expandable Myval transcatheter heart valve in a Type 0 bicuspid aortic stenosis.
- Open Access
- 7 November 2025
- Published by Sri Lanka Journals Online in Ceylon Journal of ECMO, Cardiothoracic Surgery and Critical Care
- Vol. 2 (1) , 16-21
Changes in right heart morphology and pulmonary arterial pressure following transcatheter Atrial Septal Defect (ASD) closure in adults
Introduction: Atrial septal defect (ASD) is one of the commonest congenital heart diseases. Pulmonary arterial hypertension (PAH) has been noted in 6% to 35% of patients with secundum ASD. PAH in unoperated patients with ASD has been associated with functional limitations, atrial tachyarrhythmias, heart failure, and reduced life expectancy. This study aims to evaluate right atrial and right ventricular dimensions, the severity of tricuspid regurgitation, and pulmonary arterial systolic pressure in adults before and after ASD device closure in a sample of the Nepalese population.Methods: This is a cross-sectional study on patients who underwent transcatheter ASD closure at a single centre in Nepal between January 2016 and December 2020, followed up from January 2023 to December 2023. Results: A total of 688 patients underwent ASD devise closure, of which 358 (52.03%) were available for follow-up. The cohort included patients aged 18–70 years (mean 35.8 ± 12.2 years), with a female predominance (72.9%). Device sizes ranged from 10–40 mm, with the Amplatzer septal occluder being most frequently used (95.2%). The mean follow-up duration was 58 (range 28–90) months. Prior to closure, all patients demonstrated right atrial and right ventricular dilatation, which persisted in only four (1.1%) patients post-procedure. Tricuspid regurgitation was predominantly mild to moderate before closure, with marked improvement thereafter. Mean tricuspid regurgitation pressure gradient (TRPG) decreased significantly from 47.03 ± 9.76 mmHg (range 16–92) to 13.6 ± 12.06 mmHg (range 0–90) post-closure. Pulmonary arterial hypertension (PAH), present as moderate to severe in most patients pre-procedure, was absent in the majority after closure, as assessed by echocardiography.Conclusion: ASD device closure effectively reduces right atrial and right ventricular size. TR and pulmonary artery systolic pressure in most of the cases. This study has established baseline values for the Nepalese population.
- 7 November 2025
- Published by Sri Lanka Journals Online in Ceylon Journal of ECMO, Cardiothoracic Surgery and Critical Care
- Vol. 2 (1) , 16-21
Open AccessChanges in right heart morphology and pulmonary arterial pressure following transcatheter Atrial Septal Defect (ASD) closure in adults
Introduction: Atrial septal defect (ASD) is one of the commonest congenital heart diseases. Pulmonary arterial hypertension (PAH) has been noted in 6% to 35% of patients with secundum ASD. PAH in unoperated patients with ASD has been associated with functional limitations, atrial tachyarrhythmias, heart failure, and reduced life expectancy. This study aims to evaluate right atrial and right ventricular dimensions, the severity of tricuspid regurgitation, and pulmonary arterial systolic pressure in adults before and after ASD device closure in a sample of the Nepalese population.Methods: This is a cross-sectional study on patients who underwent transcatheter ASD closure at a single centre in Nepal between January 2016 and December 2020, followed up from January 2023 to December 2023. Results: A total of 688 patients underwent ASD devise closure, of which 358 (52.03%) were available for follow-up. The cohort included patients aged 18–70 years (mean 35.8 ± 12.2 years), with a female predominance (72.9%). Device sizes ranged from 10–40 mm, with the Amplatzer septal occluder being most frequently used (95.2%). The mean follow-up duration was 58 (range 28–90) months. Prior to closure, all patients demonstrated right atrial and right ventricular dilatation, which persisted in only four (1.1%) patients post-procedure. Tricuspid regurgitation was predominantly mild to moderate before closure, with marked improvement thereafter. Mean tricuspid regurgitation pressure gradient (TRPG) decreased significantly from 47.03 ± 9.76 mmHg (range 16–92) to 13.6 ± 12.06 mmHg (range 0–90) post-closure. Pulmonary arterial hypertension (PAH), present as moderate to severe in most patients pre-procedure, was absent in the majority after closure, as assessed by echocardiography.Conclusion: ASD device closure effectively reduces right atrial and right ventricular size. TR and pulmonary artery systolic pressure in most of the cases. This study has established baseline values for the Nepalese population.
- Open Access
- 30 October 2025
- Published by Nepal Journals Online (JOL) in Nepalese Heart Journal
- Vol. 22 (2) , 71-74
Transcatheter Left Atrial Appendage Occlusion: First Case of Nepal
Transcatheter left atrial appendage occlusion (LAAO) is a valuable therapeutic option for stroke prevention in patients with non-valvular atrial fibrillation at high bleeding risk. Worldwide acceptance of LAAO therapy as an alternative to oral anticoagulation is growing. The most recent 2025 SCAI/HRS Clinical Practice Guidelines on Transcatheter Left Atrial Appendage Occlusion suggests Oral anticoagulation (OAC) or LAAO as treatment options for stroke prevention. While most patients are offered stroke prevention with OAC, those with elevated bleeding risk, prior bleeding complications, or strong preferences to avoid long-term anticoagulation would reasonably choose LAAO over OAC. In this case report we describe the first successful transcatheter LAAO in Nepal in a 75 years old male with CHA2DS2-VASc of 3 and HAS-BLED score of 3. Though he was treated with oral anticoagulation to prevent stroke but due to hemoptysis he could not continue it.TO prevent stroke patient party opted for the LAAO procedure. Under general anesthesia with Transesophageal echocardiogram guidance, patient underwent successful transcatheter LAAO with 31 mm Amulet device. He was discharged the next day of the procedure in stable condition without any complication.
- 30 October 2025
- Published by Nepal Journals Online (JOL) in Nepalese Heart Journal
- Vol. 22 (2) , 71-74
Open AccessTranscatheter Left Atrial Appendage Occlusion: First Case of Nepal
Transcatheter left atrial appendage occlusion (LAAO) is a valuable therapeutic option for stroke prevention in patients with non-valvular atrial fibrillation at high bleeding risk. Worldwide acceptance of LAAO therapy as an alternative to oral anticoagulation is growing. The most recent 2025 SCAI/HRS Clinical Practice Guidelines on Transcatheter Left Atrial Appendage Occlusion suggests Oral anticoagulation (OAC) or LAAO as treatment options for stroke prevention. While most patients are offered stroke prevention with OAC, those with elevated bleeding risk, prior bleeding complications, or strong preferences to avoid long-term anticoagulation would reasonably choose LAAO over OAC. In this case report we describe the first successful transcatheter LAAO in Nepal in a 75 years old male with CHA2DS2-VASc of 3 and HAS-BLED score of 3. Though he was treated with oral anticoagulation to prevent stroke but due to hemoptysis he could not continue it.TO prevent stroke patient party opted for the LAAO procedure. Under general anesthesia with Transesophageal echocardiogram guidance, patient underwent successful transcatheter LAAO with 31 mm Amulet device. He was discharged the next day of the procedure in stable condition without any complication.
- Open Access
- 30 June 2025
- Published by Nepal Journals Online (JOL) in Journal of National Heart and Lung Society Nepal
- Vol. 4 (1) , 73-77
Transcatheter Aortic Valve Implantation in Post Coronary Artery Bypass Graft Patient
Patients with a prior coronary artery bypass graft and severe aortic stenosis represent a unique subset. Surgical aortic valve replacement is a strong contraindication in patients with severe aortic stenosis who have a history of coronary artery bypass grafting. In this case report, we share our experience with transcatheter aortic valve implantation in a post-coronary artery bypass graft patient at Shahid Gangalal National Heart Center, an emerging transcatheter aortic valve implantation center in Nepal.
- 30 June 2025
- Published by Nepal Journals Online (JOL) in Journal of National Heart and Lung Society Nepal
- Vol. 4 (1) , 73-77
Open AccessTranscatheter Aortic Valve Implantation in Post Coronary Artery Bypass Graft Patient
Patients with a prior coronary artery bypass graft and severe aortic stenosis represent a unique subset. Surgical aortic valve replacement is a strong contraindication in patients with severe aortic stenosis who have a history of coronary artery bypass grafting. In this case report, we share our experience with transcatheter aortic valve implantation in a post-coronary artery bypass graft patient at Shahid Gangalal National Heart Center, an emerging transcatheter aortic valve implantation center in Nepal.
- 31 December 2024
- Published by Nepal Journals Online (JOL) in Journal of National Heart and Lung Society Nepal
- Vol. 4 (2) , 154-158
Patent Foramen Ovale Device Closure in Nepali Migrant Worker Performed at Shahid Gangalal National Heart Centre, Kathmandu, Nepal
Patent Foramen Ovale is highly prevalence in the general population and in patients with cryptogenic stroke. Patent Foramen Ovale device closure emerged as a practical solution to the problem of Patent Foramen Ovale-mediated illness. In patient with previous history of stroke and absence of other embolic etiologies with shunt across the Patent Foramen Ovale warrants closure. We highlight a Patent Foramen Ovale device closure of a migrant worker in Shahid Gangalal National Heart Centre.
- 31 December 2024
- Published by Nepal Journals Online (JOL) in Journal of National Heart and Lung Society Nepal
- Vol. 4 (2) , 154-158
Patent Foramen Ovale Device Closure in Nepali Migrant Worker Performed at Shahid Gangalal National Heart Centre, Kathmandu, Nepal
Patent Foramen Ovale is highly prevalence in the general population and in patients with cryptogenic stroke. Patent Foramen Ovale device closure emerged as a practical solution to the problem of Patent Foramen Ovale-mediated illness. In patient with previous history of stroke and absence of other embolic etiologies with shunt across the Patent Foramen Ovale warrants closure. We highlight a Patent Foramen Ovale device closure of a migrant worker in Shahid Gangalal National Heart Centre.
- Open Access
- 21 December 2024
- Published by Nepal Journals Online (JOL) in Journal of National Heart and Lung Society Nepal
- Vol. 3 (2) , 140-144
ASD Device Closure in Dextrocardia with Situs Inversus Totalis
Device closure of the atrial septal defect in dextrocardia with situs inversus totalis has been reported previously. Dextrocardia with situs Inversus totalis in ASD makes the procedure complex.With proper imaging ASD device closure can be done in such cases. We present a case of a 19 years old female, who underwent successful ASD device closure for the second time in our center.
- 21 December 2024
- Published by Nepal Journals Online (JOL) in Journal of National Heart and Lung Society Nepal
- Vol. 3 (2) , 140-144
Open AccessASD Device Closure in Dextrocardia with Situs Inversus Totalis
Device closure of the atrial septal defect in dextrocardia with situs inversus totalis has been reported previously. Dextrocardia with situs Inversus totalis in ASD makes the procedure complex.With proper imaging ASD device closure can be done in such cases. We present a case of a 19 years old female, who underwent successful ASD device closure for the second time in our center.
- Open Access
- 5 November 2024
- Published by Nepal Journals Online (JOL) in Nepalese Heart Journal
- Vol. 21 (2) , 43-46
Transcatheter aortic valve implantation using balloon-expandable Myval transcatheter heart valve in a patient with bicuspid aortic valve with low-flow, low-gradient severe aortic stenosis
Transcatheter aortic valve implantation is the most preferred treatment for aortic stenosis in elderly patients at high surgical risk. We share our experience with Transcatheter aortic valve implantation utilizing a balloon-expandable Myval transcatheter heart valve in a patient diagnosed with a bicuspid aortic valve, exhibiting low-flow, low-gradient severe aortic stenosis, along with annular calcification that extends to the left ventricular outflow tract and horizontal aorta.
- 5 November 2024
- Published by Nepal Journals Online (JOL) in Nepalese Heart Journal
- Vol. 21 (2) , 43-46
Open AccessTranscatheter aortic valve implantation using balloon-expandable Myval transcatheter heart valve in a patient with bicuspid aortic valve with low-flow, low-gradient severe aortic stenosis
Transcatheter aortic valve implantation is the most preferred treatment for aortic stenosis in elderly patients at high surgical risk. We share our experience with Transcatheter aortic valve implantation utilizing a balloon-expandable Myval transcatheter heart valve in a patient diagnosed with a bicuspid aortic valve, exhibiting low-flow, low-gradient severe aortic stenosis, along with annular calcification that extends to the left ventricular outflow tract and horizontal aorta.